SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-010303
Filing Date
2008-02-14
Accepted
2008-02-14 06:30:17
Documents
9
Period of Report
2008-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-4441_48k.htm 8-K 42224
2 EX-1.1 a08-4441_4ex1d1.htm EX-1.1 313438
3 EX-5.2 a08-4441_4ex5d2.htm EX-5.2 10436
4 EX-99.1 a08-4441_4ex99d1.htm EX-99.1 9845
5 EX-99.2 a08-4441_4ex99d2.htm EX-99.2 9051
6 GRAPHIC g44414kgi001.jpg GRAPHIC 8354
7 GRAPHIC g44414kgi002.jpg GRAPHIC 2264
8 GRAPHIC g44414mmi001.jpg GRAPHIC 4185
9 GRAPHIC g44414moi001.jpg GRAPHIC 4185
  Complete submission text file 0001104659-08-010303.txt   413158
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50513 | Film No.: 08607930
SIC: 2836 Biological Products, (No Diagnostic Substances)